|
Yale SPORE in Skin Cancer
|
5P50CA121974-04
|
$2,233,298
|
$2,233,298
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-31
|
$1,889,710
|
$37,794
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Xenograft-like rejection of tumors in a-gal glycolipids
|
5R01CA122019-02
|
$337,188
|
$168,594
|
GALILI, URI
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
WNT Receptor Signaling and Cancer
|
5R01CA071672-13
|
$394,741
|
$394,741
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$4,310
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010183-00580
|
$94,490
|
$4,724
|
McGlynn
|
DCEG (NCI)
|
|
VCU Minority-Based CCOP
|
3U10CA052784-19S1
|
$99,999
|
$1,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-19
|
$314,164
|
$3,142
|
Roberts, John
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-02
|
$1,500,000
|
$45,000
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Validation of Grm1 as a Therapeutic Target in Melanoma
|
3R01CA124975-03S2
|
$58,894
|
$58,894
|
GOYDOS, JAMES
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Validation of Grm1 as a Therapeutic Target in Melanoma
|
5R01CA124975-03
|
$295,488
|
$295,488
|
GOYDOS, JAMES
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Validation of genomic targets in melanoma
|
5R01CA114337-05
|
$294,871
|
$294,871
|
KASHANI-SABET, MOHAMMED
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
UT M.D. Anderson Cancer Center SPORE in Melanoma
|
3P50CA093459-05S1
|
$1,079,303
|
$1,079,303
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Uses of GEM models for Translational Cancer Research
|
1U01CA141508-01
|
$775,000
|
$387,500
|
CHIN, LYNDA
|
DANA-FARBER CANCER INSTITUTE
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-34S1
|
$74,165
|
$1,483
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-34S2
|
$100,000
|
$2,000
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-34
|
$6,658,653
|
$133,173
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-25
|
$1,884,250
|
$18,843
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S2
|
$1,678,886
|
$33,578
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S3
|
$80,987
|
$1,620
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S4
|
$99,840
|
$1,997
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
2U10CA037420-25
|
$1,533,879
|
$30,678
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-05S2
|
$60,764
|
$6,076
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-05
|
$1,371,380
|
$137,138
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-02
|
$1,463,613
|
$175,634
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Unexpected Roles for the alpha2beta1 Integrin
|
5R01CA115984-05
|
$287,453
|
$71,863
|
ZUTTER, MARY
|
VANDERBILT UNIVERSITY
|
|
UMB/DFHCC Comprehensive Cancer Partnership Program
|
5U56CA118635-05
|
$443,649
|
$66,547
|
Colon-Carmona, Adan
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
Tumor-Stroma Interacions in the Tumor Microenvironment
|
5U54CA126515-04
|
$1,854,827
|
$278,224
|
HYNES, RICHARD
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Tumor-Reactive Immune Cells Generated from Drosphila Antigen Presenting Cells
|
ZIA BC 011228
|
$215,584
|
$215,584
|
Yang, James
|
CCR (NCI)
|
|
Tumor Vaccination: Modulation of Inhibitory Signaling in Antigen-presenting cells
|
5R01CA116677-05
|
$252,841
|
$252,841
|
Chen, SiYi
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Tumor gene expression in vitro and in vivo
|
ZIA BC 008905
|
$499,664
|
$149,899
|
Lowy, Douglas
|
CCR (NCI)
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-05
|
$1,093,403
|
$109,340
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Tumor -Targeting Chemotherapeutic Agents
|
2R01CA103314-18A1
|
$322,229
|
$80,557
|
OJIMA, IWAO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Treatment of Melanoma with wild-type P53 and detectable S100B using pentamidine:
|
5R21CA135624-02
|
$311,250
|
$311,250
|
SAUSVILLE, EDWARD
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Treatment of Melanoma with Optimzed Peptide Vaccines
|
1R01CA136828-01A2
|
$346,352
|
$346,352
|
Celis, Esteban
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Translational Research in Cancer
|
3P30CA056036-10S1
|
$63,390
|
$2,536
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-10S2
|
$98,650
|
$3,946
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-10
|
$3,102,433
|
$124,097
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational linkage strategies for DNA vaccines against cancer
|
5F31CA130744-03
|
$41,176
|
$41,176
|
Alonzo, Eric
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Transduction of T-cells to improve migration to tumor
|
5R01CA116206-05
|
$282,772
|
$282,772
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Transcriptional regulation of NC precursor formation
|
5R01CA114058-05
|
$243,714
|
$121,857
|
LABONNE, CAROLE
|
NORTHWESTERN UNIVERSITY
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-26
|
$841,858
|
$8,419
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
To Understand/Augment OX40-mediated Tumor Immunotherapy
|
2R01CA102577-06A1
|
$315,735
|
$157,868
|
WEINBERG, ANDREW
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$787,346
|
$118,102
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Therapeutic Potential of IL-15 Plasmid Delivery to Tumors Using Electroporation
|
7R01CA122518-02
|
$334,194
|
$334,194
|
HELLER, RICHARD
|
OLD DOMINION UNIVERSITY
|
|
Therapeutic approaches that target cancer cell metabolism
|
5K23CA120862-02
|
$137,295
|
$96,107
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Unfolded Protein Response in Melanoma Progression and Chemoresistance
|
5R01CA125017-03
|
$224,100
|
$224,100
|
SOENGAS, MARIA
|
SPANISH NATIONAL CANCER CENTER
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-10
|
$1,884,833
|
$471,208
|
HERSCHMAN, HARVEY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
The Siteman Center of Cancer Nanotechnology Excellence *
|
5U54CA119342-05
|
$3,340,999
|
$668,200
|
WICKLINE, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
|
5R01CA071669-11
|
$374,438
|
$374,438
|
MULE, JAMES
|
H. LEE MOFFITT CANCER CTR & RES INST
|
Total relevant funding to Melanoma for this search: $103,671,511
|